| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
PERITONEAL DIALYSIS IN LATIN AMERICA |
1 Department of Internal Medicine, University Hospital, Botucatu School of Medicine, São Paulo State University (UNESP), São Paulo, Brazil; 2 Center of Nephrology, Republic University, Montevideo, Uruguay
Correspondence to: A.L. Balbi, Department of Internal Medicine, Hospital das
Clínicas da Faculdade de Medicina de Botucatu, Universidade Estadual
Paulista (UNESP), Rubião Júnior, P.O. Box 584, CEP 18618-970,
São Paulo,
Brazil.
abalbi{at}fmb.unesp.br
Peritoneal dialysis (PD), although classically described and utilized in
the treatment of patients with end-stage renal disease, can also be utilized
in the acute setting in different clinical situations. Recent studies showed
that, in patients with acute renal failure, it is possible to obtain
reasonable dialysis doses with adequate metabolic and electrolytic control and
low incidence of complications by utilizing continuous PD through a cycler at
high volume. In patients with congestive heart failure without end-stage renal
disease, PD is capable of promoting clinical improvement with slow removal of
liquids, becoming an attractive alternative for situations of rapidly or
slowly worsening cardiac function. In patients submitted to chronic
hemodialysis but who have vascular access difficulties, PD can also be
utilized as a "bridge," thereby avoiding the use of central venous
catheters, which can be associated with infectious complications such as
bacterial endocarditis. New studies must be realized showing other indications
for PD.
KEY WORDS: KEY WORDS:; Acute renal failure; end-stage renal disease; congestive heart failure.
Received 8 January 2007; accepted 5 March 2007.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
 |
